Zhejiang Cancer Hospital
Hangzhou, Zhejiang, 310022, China
NCT Number: NCT02923128
The purpose of this study is to determine whether postoperative analgesia pump continuous infusion of dexmedetomidine are effective in the prevention of Postoperative delirium and Postoperative cognitive dysfunction.
Looking for future studies?
Notify Me60 year–100 year
All sexes
Interventional
Phase 4
Hangzhou, Zhejiang, 310022, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Dexmedetomidine 3 ug/kg is diluted to 150ml with 0.9% saline,continuous micro-pump infusion for 72 hours with 2ml/h speed.
Other names: Dexmedetomidine Hydrochloride Injection
Sufentanyl 3 ug/kg is diluted to 150ml with 0.9% saline,continuous micro-pump infusion for 72 hours with 2ml/h speed.
Other names: Sufentanil Citrate Injection
Saline is used to dilute other drugs
Other names: normal saline,physiological saline,NS
Time frame: 7 days after surgery
The four clinical criteria for CAM-ICU are as follows: (1) acute onset with fluctuating course of disease; (2) inattention; (3) altered level of consciousness; (4) disorganized thinking. Delirium can be diagnosed by the appearance of both features 1 and 2, with at least one of features 3 or 4.
Time frame: 3 days after surgery
Pain was assessed by NRS (Numeric Rating Scale) : assess pain severity at that moment in time using a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable".
Time frame: 3 days after surgery
including hypotension, hypertension, bradycardia, tachycardia, hypoxemia, and in-terventions (adjustment or stop study drug infusion or intravenous administration).
Zhejiang Cancer Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05574400
Alzheimer Disease, Brain Diseases
Ann Arbor, Michigan, United States
View Trial DetailsNCT06392919
Chronic Post-surgical Pain, Cognition Disorders
Nantong, Jiangsu, China
View Trial DetailsNCT03683537
Astrogliosis, Cognition Disorders
Moscow, Russia
View Trial DetailsNCT03802396
Cognition Disorders, Cognitive Dysfunction
Durham, North Carolina, United States
View Trial Details